Search Within

Miguel-Angel Perales

Formats
  1. Meeting Abstract (498)
  2. Journal Article (361)
  3. Review (29)
  4. Research Letter (18)
  5. Guidelines (12)
  6. Book Section (10)
  7. Correspondence (5)
  8. Editorial (5)
  9. Book Whole (1)
  10. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (940)
  2. Center for Hematologic Malignancies (940)
  3. Department of Medicine (940)
  4. Hematologic Malignancies, Division of (940)
  5. Survivorship Research (473)
  6. CTCR Scholars (410)

More Groups

People
  1. Sergio Giralt (428)
  2. Sean Devlin (302)
  3. Ann Jakubowski (247)
  4. Esperanza Papadopoulos (237)
  5. Gunjan Shah (203)
  6. Molly Maloy (196)

More People

Years
  1. 2025 (28)
  2. 2024 (76)
  3. 2023 (101)
  4. 2022 (95)
  5. 2021 (68)
  6. 2020 (93)

More Years

Publications
  1. Blood (263)
  2. Biology of Blood and Marrow Transplantation (220)
  3. Bone Marrow Transplantation (86)
  4. Transplantation and Cellular Therapy (68)
  5. Blood Advances (46)
  6. Journal of Clinical Oncology (32)

More Publications

Publishers
  1. American Society of Hematology (311)
  2. Elsevier Inc. (302)
  3. Nature Publishing Group (112)
  4. American Society of Clinical Oncology (32)
  5. Oxford University Press (18)
  6. John Wiley & Sons (17)

More Publishers

Results (940)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Challenges and Potential Solutions for Recruitment and Retention of Hematopoietic Cell Transplantation Physicians: The National Marrow Donor Program's System Capacity Initiative Physician Workforce Group Report
    Journal Article

    Burns, L. J.; Gajewski, J. L.; Majhail, N. S.; Navarro, W.; Perales, M. A.; Shereck, E.; Selby, G. B.; Snyder, E. L.; Woolfrey, A. E.; Litzow, M. R.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committee
    Journal Article

    Bubalo, J.; Carpenter, P. A.; Majhail, N.; Perales, M. A.; Marks, D. I.; Shaughnessy, P.; Pidala, J.; Leather, H. L.; Wingard, J.; Savani, B. N.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • A Phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with BCell lymphoid malignancies: Favorably durable event-free survival in chemosensitive patients
    Journal Article

    Sauter, C. S.; Barker, J. N.; Lechner, L.; Zheng, J.; Devlin, S. M.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Goldberg, J. D.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: A comparison with allografts from adult unrelated donors
    Journal Article

    Marks, D. I.; Woo, K. A.; Zhong, X.; Appelbaum, F. R.; Bachanova, V.; Barker, J. N.; Brunstein, C. G.; Gibson, J.; Kebriaei, P.; Lazarus, H. M.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil (MMF) dosing every 8 hours is safe from the standpoint of engraftment and may ameliorate severe acute graft-versus-host disease (GVHD) after double-unit cord blood transplantation (CBT)
    Meeting Abstract

    Ponce, D. M.; Harnicar, S. J.; Devlin, S.; Hilden, P.; Evans, K. L.; Lubin, M. N.; Giralt, S. A.; Goldberg, J. D.; Perales, M. A.; Kernan, N. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation is effective in patients with advanced systemic mastocytosis: A multicenter retrospective analysis
    Meeting Abstract

    Ustun, C.; Reiter, A.; Scott, B. L.; Nakamura, R.; Gandhi, D.; Kreil, S.; Shanley, R.; Hogan, W. J.; Perales, M. A.; Shore, T. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Low CD34 cell dose is associated with higher non-relapse and overall mortality after reduced intensity conditioning hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
    Meeting Abstract

    Thörlén, J.; Ringdén, O.; Le Rademacher, J.; Battiwalla, M.; Chen, J.; Ho, V. T.; Kebriaei, P.; Keever-Taylor, C. A.; Kindwall-Keller, T. L.; Lazarus, H. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS
    Meeting Abstract

    Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Outcomes in patients with acute lymphoblastic leukemia in first or second complete remission receiving ex-vivo T-cell depleted or unmodified allografts: Comparison of results at two institutions
    Meeting Abstract

    Hobbs, G. S.; Hilden, P.; Hamdi, A.; Goldberg, J. D.; Poon, M.; Ledesma, C.; Devlin, S.; Rondon, G.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Blood (2013)

    Fulltext@MSK | Save